Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards
Human pluripotent stem cell derived therapies can have serious safety risks. Here the authors design two drug inducible genetic safeguards to deplete undifferentiated hPSCs and hPSC-derived cell types.
Guardado en:
Autores principales: | Renata M. Martin, Jonas L. Fowler, M. Kyle Cromer, Benjamin J. Lesch, Ezequiel Ponce, Nobuko Uchida, Toshinobu Nishimura, Matthew H. Porteus, Kyle M. Loh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1bf355be0de745bc987455ce3536745a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silencing of the lncRNA Zeb2-NAT facilitates reprogramming of aged fibroblasts and safeguards stem cell pluripotency
por: Bruno Bernardes de Jesus, et al.
Publicado: (2018) -
Safeguarding our soils
Publicado: (2017) -
LSD1-mediated demethylation of OCT4 safeguards pluripotent stem cells by maintaining the transcription of PORE-motif-containing genes
por: Songsong Dan, et al.
Publicado: (2021) -
Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
por: Mehmet Fatih Bolukbasi, et al.
Publicado: (2018) -
Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing
por: Mehmet Fatih Bolukbasi, et al.
Publicado: (2018)